NCT01776528View on ClinicalTrials.gov

Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Diabetes Mellitus
Interventions
BIOLOGICAL

NGM282

BIOLOGICAL

Placebo

Trial Locations (1)

6009

NGM Clinical Study Site, Perth

Sponsors
All Listed Sponsors
lead

NGM Biopharmaceuticals, Inc

INDUSTRY

NCT01776528 - Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter